Industry

Innovative anesthesia delivery puts women’s health first, saving patients time and reducing cost and risk of unintentional dural puncture, which can lead to severe and chronic headaches ROSELAND, N.J.–(BUSINESS WIRE)–With post epidural side effects becoming more serious than previously known, today Milestone Scientific Inc. announced the availability of its CompuFlo® Epidural instrument in hospitals and … [Read more…]

  NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA. The study’s key findings reveal that patients who used high frequency chest wall oscillation (“HFCWO”) therapy experienced an improvement in … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Xponential Fitness, Inc. (NYSE: XPOF) (the “Company” or “Xponential Fitness”), the largest global franchisor of boutique fitness brands, today announced Anthony Geisler, Chief Executive Officer; John Meloun, Chief Financial Officer; and Sarah Luna, President, will participate in the following upcoming investor conferences: The Credit Suisse HALO Investment Summit to be held May 24-25, … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at … [Read more…]

BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of … [Read more…]

-Expanded clinical development presence is expected to accelerate activities for THIO-101 Phase 2 Trial for NSCLC- CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that the company has established two wholly-owned subsidiaries in Romania and Australia to broaden and accelerate its global development plan … [Read more…]

The appointment will support Biognosys’ transformation to a leading provider of protein insights for the development of new breakthrough treatments ZURICH–(BUSINESS WIRE)–#ClinicalResearch–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat Lüthi, Ph.D., as Board Director. Dr. Lüthi is Chief Executive Officer of CTC Analytics … [Read more…]

– Data show that combination of two antibodies in Immunome’s cocktail successfully neutralized the Omicron variant in vivo in hamsters – – IMM20253 antibody also retained activity against BA.2 subvariant in pseudovirus testing in vitro, with additional testing underway – EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B … [Read more…]

ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac™ 2.0 Soft Tissue Fixation System. The TenoTac™ 2.0 Soft Tissue Fixation System uses a titanium threaded implant and … [Read more…]

New post-hoc data accepted as late breaking abstracts at the 90th European Atherosclerosis Society (EAS) Congress and 2022 National Lipid Association (NLA) Scientific Sessions NAARDEN, Netherlands & MIAMI–(BUSINESS WIRE)–NewAmsterdam Pharma (NewAmsterdam), a clinical-stage company focused on the research and development of transformative oral therapies for metabolic diseases, today announced that it will present new post-hoc … [Read more…]